Use of a multidisciplinary tool to achieve target outcomes in Native American patients with diabetes: Treat-to-target
Emily L Sexson, Michael S Monaghan, Thomas L Lenz, Ann Ryan Haddad, Gail Jensen, Gary Elsasser
Creighton University School of Pharmacy and Health Professions, Omaha, NE, USA
Purpose: Our purpose was to test a communication tool used in a multidisciplinary setting to more effectively achieve the recommended goals for glucose, blood pressure, lipids, and prophylactic aspirin use in a Native American population with type 2 diabetes.
Methods: One hundred randomly selected patients were included in this observational, preintervention, post-intervention study design. The team began with a chart audit documenting hemoglobin A1c (Hgb A1c), blood pressure, cholesterol levels, and aspirin use. The intervention included the development of a one page form used to prompt providers to intensify therapy when the patient was not meeting evidence-based goals. The audit was repeated one year later.
Results: Analysis of 74 patients completing the study showed a decrease in Hgb A1C from 8.812% pre-intervention to a mean 8.214% post-intervention (p < 0.007). At the time of pre-intervention audit, patients were already at target for blood pressure and no significant further decrease was found. Measures of total cholesterol, triglycerides, and aspirin use showed improvement, but statistical significance was not met.
Conclusion: The one-page multidisciplinary tool used to intensify therapy significantly improved glucose control. More consistent interaction of the multidisciplinary team is necessary to reach other desired goals.
Keywords: diabetes, multidisciplinary, treat-to-target, Native American
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]